Trial Profile
Investigation to Minimize Prolapse Recurrence of the Vagina Using Estrogen
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Sep 2023
Price :
$35
*
At a glance
- Drugs Conjugated estrogens (Primary)
- Indications Uterine diseases
- Focus Therapeutic Use
- Acronyms IMPROVE
- 23 Aug 2023 Status changed from active, no longer recruiting to completed.
- 30 Sep 2021 Planned primary completion date changed from 31 Aug 2021 to 31 Oct 2021.
- 29 Jul 2021 Planned primary completion date changed from 30 Jun 2021 to 31 Aug 2021.